Skip to main content
. 2016 Oct 26;7(48):78918–78931. doi: 10.18632/oncotarget.12912

Table 3. Univariate log—rank and multivariate analyses for disease-specific and metastasis-free survivals in upper urinary tract urothelial carcinoma.

Parameter Category Case No. Disease-specific Survival Metastasis-free Survival
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
No. of event p-value R.R. 95% C.I. p-value No. of event p-value R.R. 95% C.I. p-value
Gender Male 158 28 0.8286 32 0.7904
Female 182 33 38
Age (years) < 65 138 26 0.9943 30 0.8470
≥ 65 202 35 40
Tumor side Right 177 34 0.7366 38 0.3074
Left 154 26 32
Bilateral 9 1 0
Tumor location Renal pelvis 141 24 0.0079* 1 0.822 31 0.0659
Ureter 150 22 0.712 0.200–2.538 25
Renal pelvis & ureter 49 15 0.848 0.217–3.308 14
Multifocality Single 273 48 0.0026* 1 0.010`* 52 0.0127* 1 0.010*
Multifocal 62 18 2.774 1.274–6.039 18 2.569 1.480–4.460
Primary tumor (T) Ta 89 2 < 0.0001* 1 0.033* 4 < 0.0001* 1 0.260
T1 92 9 3.919 0.832–18.450 15 3.314 1.072–10.248
T2-T4 159 50 5.163 1.137–23.439 51 2.729 0.969–8.580
Nodal metastasis Negative (N0) 312 42 < 0.0001* 1 < 0.001* 55 < 0.0001* 1 0.001*
Positive (N1–N2) 28 19 5.178 2.837–9.450 15 2.877 1.564–5.292
Histological grade Low grade 56 4 0.0215* 1 0.044* 3 0.0027* 1 0.023
High grade 284 57 2.964 1.030–8.534 67 3.926 1.208–12.758
Vascular invasion Absent 234 24 < 0.0001* 1 0.176 26 < 0.0001* 1 0.008*
Present 106 37 1.504 0.833–2.717 44 2.237 1.230–4.069
Perineural invasion Absent 321 50 < 0.0001* 1 < 0.001* 61 < 0.0001* 1 0.008*
Present 19 11 3.773 1.804–7.894 9 2.749 1.295–5.835
Mitotic rate (per 10 high power fields) < 10 173 27 0.167 30 0.0823
>= 10 167 34 40
DDR2 expression Low 170 13 < 0.0001* 1 0.003 15 < 0.0001* 1 < 0.001*
High 170 48 2.637 1.404–4.949 55 2.797 1.572–4.975
*

Statistically significant